GlassScriptPhysician profile
Carrie Ann Cusack
NPI 1649238775
$1,351.61
in general payments reported to CMS, 2019-2025
16 companies · $624 in 2025
The $624 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $54.08 · 2023: $278 · 2024: $396 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.89 |
| Education | $109.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $328.59 | 2022-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $228.86 | 2024-2025 | Nemluvio, Aklief |
| Abbvie INC. | $222.96 | 2024-2025 | |
| Sensus Healthcare, INC. | $105.39 | 2024 | |
| Janssen Biotech, INC. | $99.99 | 2023 | Tremfya |
| Pfizer INC. | $92.88 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $47.33 | 2022-2025 | |
| Genzyme Corporation | $36.38 | 2025 | |
| Strata Skin Sciences, INC. | $33.52 | 2025 | Xtrac |
| Leo Pharma INC. | $30.16 | 2024 | Adbry |
| Dermavant Sciences, INC. | $29.85 | 2022-2024 | Vtama |
| Organon LLC | $28.61 | 2025 | Vtama |
| Amgen INC. | $20.11 | 2025 | Otezla |
| Sun Pharmaceutical Industries INC. | $17.16 | 2023 | Odomzo, Blu-U |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.77 | 2024 | Spevigo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $14.05 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Cusack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.